{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:06:25Z","timestamp":1793437585234,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["N01 MH900001"],"award-info":[{"award-number":["N01 MH900001"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH074027"],"award-info":[{"award-number":["MH074027"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.schres.2017.05.001","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T09:30:47Z","timestamp":1494235847000},"page":"131-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["A computational algorithm for personalized medicine in schizophrenia"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5489-6960","authenticated-orcid":false,"given":"Beom S.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Gentle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan Sook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Chiriboga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yena","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie A.","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.schres.2017.05.001_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055239","article-title":"Genotype-based ancestral background consistently predicts efficacy and side effects across treatments in CATIE and STAR* D","volume":"8","author":"Adkins","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2017.05.001_bb0010","series-title":"Modeling Contextual Effects in Longitudinal Studies","first-page":"255","article-title":"Modeling complex interactions: person-centered and variable-centered approaches","author":"Bauer","year":"2007"},{"issue":"2","key":"10.1016\/j.schres.2017.05.001_bb0015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.schres.2011.07.031","article-title":"Analysis of efficacy and side effects in CATIE demonstrates drug response subgroups and potential for personalized medicine","volume":"132","author":"Clark","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.05.001_bb0020","series-title":"Cluster Analysis","author":"Everitt","year":"2011"},{"issue":"3","key":"10.1016\/j.schres.2017.05.001_bb0025","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1353\/mpq.2006.0032","article-title":"Person-oriented and variable-oriented research: concepts, results, and development","volume":"52","author":"von Eye","year":"2006","journal-title":"Merrill-Palmer Q."},{"issue":"1","key":"10.1016\/j.schres.2017.05.001_bb0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.mp.4001571","article-title":"Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework","volume":"10","author":"Fanous","year":"2005","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.05.001_bb0035","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2307\/2528823","article-title":"A general coefficient of similarity and some of its properties","volume":"27","author":"Gower","year":"1971","journal-title":"Biometrics"},{"issue":"10","key":"10.1016\/j.schres.2017.05.001_bb0040","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/GIM.0b013e3181863239","article-title":"Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE study","volume":"10","author":"Grossman","year":"2008","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.schres.2017.05.001_bb0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMp1006304","article-title":"The path to personalized medicine","volume":"363","author":"Hamburg","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.schres.2017.05.001_bb0050","series-title":"Finding Groups in Data: An Introduction to Cluster Analysis","author":"Kaufman","year":"2008"},{"issue":"2","key":"10.1016\/j.schres.2017.05.001_bb0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2017.05.001_bb0060","doi-asserted-by":"crossref","DOI":"10.1192\/S0007125000291514","article-title":"The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation","author":"Kay","year":"1989","journal-title":"Br. J. Psychiatry"},{"issue":"5646","key":"10.1016\/j.schres.2017.05.001_bb0065","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1126\/science.1092132","article-title":"The genetics of adult-onset neuropsychiatric disease: complexities and conundra?","volume":"302","author":"Kennedy","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.schres.2017.05.001_bb0070","series-title":"Applied Predictive Modeling","author":"Kuhn","year":"2013"},{"issue":"1","key":"10.1016\/j.schres.2017.05.001_bb0075","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/21642850.2014.924857","article-title":"A clustering method to identify who benefits most from the treatment group in clinical trials","volume":"2","author":"Lee","year":"2014","journal-title":"Health Psychol. Behav. Med.: Open Access J."},{"issue":"12","key":"10.1016\/j.schres.2017.05.001_bb0080","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"7265","key":"10.1016\/j.schres.2017.05.001_bb0085","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.schres.2017.05.001_bb0090","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/mp.2009.89","article-title":"Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics","volume":"16","author":"McClay","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2017.05.001_bb0095","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/FPC.0b013e32833d7b45","article-title":"Genome-wide association studies in pharmacogenomics: successes and lessons","volume":"23","author":"Motsinger-Reif","year":"2013","journal-title":"Pharmacogenet. Genomics"},{"issue":"7","key":"10.1016\/j.schres.2017.05.001_bb0100","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/ejhg.2008.264","article-title":"Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis","volume":"17","author":"Need","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.schres.2017.05.001_bb0105","doi-asserted-by":"crossref","first-page":"555","DOI":"10.31887\/DCNS.2014.16.4\/jpouget","article-title":"Pharmacogenetics and outcome with antipsychotic drugs","volume":"16","author":"Pouget","year":"2014","journal-title":"Dialogues Clin. Neurosci."},{"issue":"7510","key":"10.1016\/j.schres.2017.05.001_bb0110","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics Consortium","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.schres.2017.05.001_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.schbul.a006986","article-title":"The National Institute of Mental Health clinical antipsychotic trials of Intervention effectiveness (CATIE) project: schizophrenia trial design and protocol development","volume":"29","author":"Stroup","year":"2003","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2017.05.001_bb0120","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/mp.2008.25","article-title":"Genomewide association for schizophrenia in the CATIE study: results of stage 1","volume":"13","author":"Sullivan","year":"2008","journal-title":"Mol. Psychiatry"},{"issue":"7256","key":"10.1016\/j.schres.2017.05.001_bb0125","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","article-title":"Common polygenic variation contributes to risk of schizophrenia and bipolar disorder","volume":"460","author":"The International Schizophrenia Consortium","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.schres.2017.05.001_bb0130","series-title":"Pattern Recognition","author":"Theodoridis","year":"2008"},{"issue":"10","key":"10.1016\/j.schres.2017.05.001_bb0135","doi-asserted-by":"crossref","first-page":"680","DOI":"10.7326\/0003-4819-154-10-201105170-00008","article-title":"Interpretation of subgroup analyses in randomized trials: heterogeneity versus secondary interventions","volume":"154","author":"VanderWeele","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.schres.2017.05.001_bb0140","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.biopsych.2016.06.028","article-title":"An examination of polygenic score risk prediction in individuals with first-episode psychosis","volume":"81","author":"Vassos","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2017.05.001_bb0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/17425255.2011.532787","article-title":"Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction","volume":"7","author":"Zhang","year":"2011","journal-title":"Expert Opin. Drug Metab. Toxicol."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417302608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417302608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:30:51Z","timestamp":1760297451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417302608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":29,"alternative-id":["S0920996417302608"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.05.001","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A computational algorithm for personalized medicine in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}